Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison C Tree

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
BMJ Open|May 7, 2026
Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trialSian Cooper, Sophie Alexander, Dylan Breitkreutz, et al.
International Journal of Radiation Oncology, Biology, Physics|November 28, 2025
Primary Endpoint Analysis of the Phase 2 DESTINATION-MRL Trial for Patients With Intermediate-Risk Prostate CancerMathijs G Dassen, Alison C Tree, Lisa Wiersema, et al.
Clinical and Translational Radiation Oncology|March 5, 2024
MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM studyKobika Sritharan, Lois Daamen, Angela Pathmanathan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 23, 2018
Magnetic Resonance Imaging-Guided Adaptive Radiation Therapy: A "Game Changer" for Prostate Treatment?Angela U Pathmanathan, Nicholas J van As, Linda G W Kerkmeijer, et al.
European Urology|September 12, 2024
Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised TrialNicholas van As, Binnaz Yasar, Clare Griffin, et al.
Technical Innovations & Patient Support in Radiation Oncology|January 19, 2023
Interobserver variation of clinical oncologists compared to therapeutic radiographers (RTT) prostate contours on T2 weighted MRIGillian Adair Smith, Alex Dunlop, Sophie E Alexander, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 7, 2023
Evaluation of therapeutic radiographer contouring for magnetic resonance image guided online adaptive prostate radiotherapyGillian Adair Smith, Alex Dunlop, Sophie E Alexander, et al.
International Journal of Radiation Oncology, Biology, Physics|March 11, 2025
Stereotactic Body Radiation Therapy for Oligoprogressive Disease in Androgen-Suppressed Prostate Cancer: Primary Endpoint Analysis of the TRAP TrialPriyanka Patel, Sabine Dreibe, Gerhardt Attard, et al.
International Journal of Radiation Oncology, Biology, Physics|May 22, 2025
HERMES: Randomized Trial of 2-Fraction or 5-Fraction Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation TherapySian Cooper, Rosalyne L Westley, Katie Biscombe, et al.
Practical Radiation Oncology|December 3, 2022
Magnetic Resonance-Guided Adaptive Radiation Therapy for Prostate Cancer: The First Results from the MOMENTUM study-An International Registry for the Evidence-Based Introduction of Magnetic Resonance-Guided Adaptive Radiation TherapyFrederik R Teunissen, Thomas Willigenburg, Alison C Tree, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
BMJ Open|May 7, 2026
Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trialSian Cooper, Sophie Alexander, Dylan Breitkreutz, et al.
International Journal of Radiation Oncology, Biology, Physics|November 28, 2025
Primary Endpoint Analysis of the Phase 2 DESTINATION-MRL Trial for Patients With Intermediate-Risk Prostate CancerMathijs G Dassen, Alison C Tree, Lisa Wiersema, et al.
Clinical and Translational Radiation Oncology|March 5, 2024
MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM studyKobika Sritharan, Lois Daamen, Angela Pathmanathan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 23, 2018
Magnetic Resonance Imaging-Guided Adaptive Radiation Therapy: A "Game Changer" for Prostate Treatment?Angela U Pathmanathan, Nicholas J van As, Linda G W Kerkmeijer, et al.
European Urology|September 12, 2024
Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised TrialNicholas van As, Binnaz Yasar, Clare Griffin, et al.
Technical Innovations & Patient Support in Radiation Oncology|January 19, 2023
Interobserver variation of clinical oncologists compared to therapeutic radiographers (RTT) prostate contours on T2 weighted MRIGillian Adair Smith, Alex Dunlop, Sophie E Alexander, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 7, 2023
Evaluation of therapeutic radiographer contouring for magnetic resonance image guided online adaptive prostate radiotherapyGillian Adair Smith, Alex Dunlop, Sophie E Alexander, et al.
International Journal of Radiation Oncology, Biology, Physics|March 11, 2025
Stereotactic Body Radiation Therapy for Oligoprogressive Disease in Androgen-Suppressed Prostate Cancer: Primary Endpoint Analysis of the TRAP TrialPriyanka Patel, Sabine Dreibe, Gerhardt Attard, et al.
International Journal of Radiation Oncology, Biology, Physics|May 22, 2025
HERMES: Randomized Trial of 2-Fraction or 5-Fraction Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation TherapySian Cooper, Rosalyne L Westley, Katie Biscombe, et al.
Practical Radiation Oncology|December 3, 2022
Magnetic Resonance-Guided Adaptive Radiation Therapy for Prostate Cancer: The First Results from the MOMENTUM study-An International Registry for the Evidence-Based Introduction of Magnetic Resonance-Guided Adaptive Radiation TherapyFrederik R Teunissen, Thomas Willigenburg, Alison C Tree, et al.
Pageof 11